<DOC>
	<DOC>NCT02933879</DOC>
	<brief_summary>A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi- Site Phase 2b Clinical Study to Assess the Efficacy, Safety and Tolerability of 8-Week Regimens of NVXT topical product in Patients with Mild to Moderate Onychomycosis</brief_summary>
	<brief_title>Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Site Phase 2b Clinical Study</brief_title>
	<detailed_description>Evaluate safety and tolerability of the two regimens of NVXT (Treatment Groups A and B) in patients with mild to moderate distal subungual onychomycosis of the target toenail.</detailed_description>
	<mesh_term>Onychomycosis</mesh_term>
	<criteria>Clinical diagnosis of onychomycosis of the target toenail (defined as one of the infected great toenails). Females who are pregnant, lactating or likely to become pregnant during the study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>